Innate versus adaptive immunity: A paradigm past its prime?

Cancer Research

Volumn 67, Issue 9, 2007, Pages 3989-3993

  Borghesi, Lisa ^a   Milcarek, Christine ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE IMMUNITY; ANTIGEN SPECIFICITY; CANCER RESEARCH; CELL POPULATION; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; MEMORY CELL; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR IMMUNOLOGY;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; HUMANS; IMMUNITY, NATURAL; NEOPLASMS;

EID: 34249280244     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-0182     Document Type: Review

References (42)

1. Bendelac AM, Bonneville JF. Kearney. Autoreactivity by design: innate B and T lymphocytes. Nat Rev Immunol 2001;1:177-86.
2. Haas KM, Poe JC, Steeber DA, Tedder TF. B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. Immunity 2005; 23:7-18.
3. Parham P. Immunology: adaptable innate killers. Nature 2006;441:415-6.
4. Goodyear CS, Silverman GJ. Staphylococcal toxin induced preferential and prolonged in vivo deletion of innate-like B lymphocytes. Proc Natl Acad Sci U S A 2004;101:11392-7.
5. Kearney JF. Innate-like B cells. Springer Semin Immunopathol 2005;26:377-83.
6. Savitsky D, Calame K. B-1 B lymphocytes require Blimp-1 for immunoglobulin secretion. J Exp Med 2006; 203:2305-14.
7. Konigshofer Y, Chien YH. Gammadelta T cells: innate immune lymphocytes? Curr Opin Immunol 2006;18: 527-33.
8. + T cells during mycobacterial infections. Science 2002;295:2255-8.
9. O'Leary JG, Goodarzi M, Drayton DL, von Andrian UH. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat Immunol 2006;7: 507-16.
10. Puellmann K, Kaminski WE, Vogel M, et al. From the Cover: a variable immunoreceptor in a subpopulation of human neutrophils. Proc Natl Acad Sci U S A 2006;103: 14441-6.
11. Godfrey DI, MacDonald HR, Kronenberg M, Smyth MJ, Van Kaer L. NKT cells: what's in a name? Nat Rev Immunol 2004;4:231-7.
12. + intraepithelial lymphocyte precursors in the thymus. Immunity 2006;25:631-41.
13. Kantor AB, Merrill CE, Herzenberg LA, Hillson JL. An unbiased analysis of V(H)-D-J(H) sequences from B-1a, B-1b, and conventional B cells. J Immunol 1997;158: 1175-86.
14. Hardy RR. B-1 B cell development. J Immunol 2006; 177:2749-54.
15. Martin F, Kearney JF. Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk. Immunity 2000;12: 39-49.
16. Vivier E, Malissen B. Innate and adaptive immunity: specificities and signaling hierarchies revisited. Nat Immunol 2005;6:17-21.
17. Terabe M, Swann J, Ambrosino E, et al. A nonclassical non-Valpha14Jalpha18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance. J Exp Med 2005;202:1627-33.
18. Motohashi S, Ishikawa A, Ishikawa E, et al. A phase I study of in vitro expanded natural killer T cells in patients with advanced and recurrent non-small cell lung cancer. Clin Cancer Res 2006;12:6079-86.
19. Tanaka Y. Human gamma delta T cells and tumor immunotherapy. J Clin Exp Hematop 2006;46:11-23.
20. Guo BL, Liu Z, Aldrich WA, Lopez RD. Innate antibreast cancer immunity of apoptosis-resistant human gammadelta-T cells. Breast Cancer Res Treat 2005;93: 169-75.
21. Lozupone F, Pende D, Burgio VL, et al. Effect of human natural killer and gammadelta T cells on the growth of human autologous melanoma xenografts in SCID mice. Cancer Res 2004;64:378-85.
22. Ebert LM, Meuter S, Moser B. Homing and function of human skin gammadelta T cells and NK cells: relevance for tumor surveillance. J Immunol 2006;176: 4331-6.
23. Skeen MJ, Ziegler HK. Induction of murine peritoneal gamma/delta T cells and their role in resistance to bacterial infection. J Exp Med 1993;178:971-84.
24. Leavy O. Adaptive Killers. Nature 2006;6:430.
25. Alugupalli KR, Leong JM, Woodland RT, Muramatsu M, Honjo T, Gerstein RM. B1b lymphocytes confer T cell-independent long-lasting immunity. Immunity 2004;21: 379-90.
26. Hayday AC. [gamma] [delta] cells: a right time and a right place for a conserved third way of protection. Annu Rev Immunol 2000;18:975-1026.
27. Borghesi L, Gerstein RM. Developmental separation of V(D)J recombinase expression and initiation of IgH recombination in B lineage progenitors in vivo. J Exp Med 2004;199:483-9.
28. Borghesi L, Hsu LY, Miller JP, et al. B lineage-specific regulation of V(D)J recombinase activity is established in common lymphoid progenitors. J Exp Med 2004;199: 491-502.
29. Bach JF, Bendelac A, Brenner MB, et al. The role of innate immunity in autoimmunity. J Exp Med 2004;200: 1527-31.
30. Yamagata T, Benoist C, Mathis D. A shared gene-expression signature in innate-like lymphocytes. Immunol Rev 2006;210:52-66.
31. Moore TA, Moore BB, Newstead MW, Standiford TJ. Gamma delta-T cells are critical for survival and early proinflammatory cytokine gene expression during murine Klebsiella pneumonia. J Immunol 2000;165: 2643-50.
32. Weiner HL, Frenkel D. Immunology and immunotherapy of Alzheimer's disease. Nat Rev Immunol 2006;6: 404-16.
33. Balazs M, Martin F, Zhou T, Kearney J. Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity 2002;17:341-52.
34. Montecino-Rodriguez E, Leathers H, Dorshkind K. Bipotential B-macrophage progenitors are present in adult bone marrow. Nat Immunol 2001;2:83-8.
35. Greaves MF, Chan LC, Furley AJ, Watt SM, Molgaard HV. Lineage promiscuity in hemopoietic differentiation and leukemia. Blood 1986;67:1-11.
36. Rumfelt LL, Zhou Y, Rowley BM, Shinton SA, Hardy RR. Lineage specification and plasticity in CD19- early B cell precursors. J Exp Med 2006;203:675-87.
37. Lieber MR, Yu K, Raghavan SC. Roles of nonhomologous DNA end joining, V(D)J recombination, and class switch recombination in chromosomal translocations. DNA Repair (Amst) 2006;5:1234-45.
38. Bergsagel PL, Kuehl WM. Chromosome translocations in multiple myeloma. Oncogene 2001;20:5611-22.
39. Loughran TP, Hadlock KG, Jr., Yang Q, et al. Seroreactivity to an envelope protein of human T-cell leukemia/lymphoma virus in patients with CD3- (natural killer) lymphoproliferative disease of granular lymphocytes. Blood 1997;90:1977-81.
40. MacLeod RA, Nagel S, Kaufmann M, Greulich-Bode K, Drexler HG. Multicolor-FISH analysis of a natural killer cell line (NK-92). Leuk Res 2002;26:1027-33.
41. Santucci M, Pimpinelli N, Massi D, et al. Cytotoxic/ natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop. Cancer 2003;97:610-27.
42. Elliott MA. Chronic neutrophilic leukemia and chronic myelomonocytic leukemia: WHO defined. Best Pract Res Clin Haematol 2006;19:571-93.